Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 29998876 | DISPLAY SCREEN WITH GRAPHICAL USER INTERFACE | April 2025 | May 2025 | Allow | 1 | 0 | 0 | No | No |
| 29990436 | Computer screen with graphical user interface | February 2025 | July 2025 | Allow | 5 | 0 | 0 | No | No |
| 29989360 | DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACE | February 2025 | October 2025 | Allow | 9 | 0 | 0 | No | No |
| 29989368 | DISPLAY SCREEN WITH ANIMATED GRAPHICAL USER INTERFACE | February 2025 | November 2025 | Allow | 9 | 0 | 0 | No | No |
| 29987981 | DISPLAY SCREEN WITH GRAPHICAL USER INTERFACE | January 2025 | August 2025 | Allow | 6 | 1 | 0 | No | No |
| 29980489 | DISPLAY SCREEN OR PORTION THEREOF WITH TRANSITIONAL GRAPHICAL USER INTERFACE OF X-RAY ANALYSIS APPARATUS | December 2024 | September 2025 | Allow | 9 | 0 | 0 | No | No |
| 29979883 | DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACE | December 2024 | October 2025 | Allow | 9 | 0 | 0 | No | No |
| 29979899 | DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACE | December 2024 | October 2025 | Allow | 9 | 0 | 0 | No | No |
| 29979885 | DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACE | December 2024 | October 2025 | Allow | 9 | 0 | 0 | No | No |
| 29979887 | DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACE | December 2024 | October 2025 | Allow | 9 | 0 | 0 | No | No |
| 29979357 | DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACE | December 2024 | August 2025 | Allow | 8 | 0 | 0 | No | No |
| 29979092 | DISPLAY SCREEN WITH GRAPHICAL USER INTERFACE FOR BACTERIA MEASURING INSTRUMENT | December 2024 | September 2025 | Allow | 9 | 0 | 0 | No | No |
| 29979116 | DISPLAY SCREEN WITH GRAPHICAL USER INTERFACE FOR BACTERIA MEASURING INSTRUMENT | December 2024 | September 2025 | Allow | 9 | 0 | 0 | No | No |
| 29979085 | DISPLAY SCREEN WITH GRAPHICAL USER INTERFACE FOR BACTERIA MEASURING INSTRUMENT | December 2024 | September 2025 | Allow | 9 | 0 | 0 | No | No |
| 29979095 | DISPLAY SCREEN WITH GRAPHICAL USER INTERFACE FOR BACTERIA MEASURING INSTRUMENT | December 2024 | September 2025 | Allow | 9 | 0 | 0 | No | No |
| 29979082 | DISPLAY SCREEN WITH ANIMATED GRAPHICAL USER INTERFACE FOR BACTERIA MEASURING INSTRUMENT | December 2024 | September 2025 | Allow | 9 | 0 | 0 | No | No |
| 29979109 | DISPLAY SCREEN WITH GRAPHICAL USER INTERFACE FOR BACTERIA MEASURING INSTRUMENT | December 2024 | September 2025 | Allow | 9 | 0 | 0 | No | No |
| 29979088 | DISPLAY SCREEN WITH ANIMATED GRAPHICAL USER INTERFACE FOR BACTERIA MEASURING INSTRUMENT | December 2024 | September 2025 | Allow | 9 | 0 | 0 | No | No |
| 29978260 | Display Screen or Portion Thereof with Animated Graphical User Interface | December 2024 | August 2025 | Allow | 9 | 0 | 0 | No | No |
| 29978280 | Display Screen or Portion Thereof with Graphical User Interface | December 2024 | August 2025 | Allow | 9 | 0 | 0 | No | No |
| 29978282 | Display Screen or Portion Thereof with Animated Graphical User Interface | December 2024 | August 2025 | Allow | 9 | 0 | 0 | No | No |
| 29977852 | DISPLAY SCREEN OR PORTION THEREOF WITH A TRANSITIONAL GRAPHICAL USER INTERFACE | December 2024 | June 2025 | Allow | 6 | 0 | 0 | No | No |
| 29977173 | Display Screen with Graphical User Interface | December 2024 | August 2025 | Allow | 9 | 0 | 0 | No | No |
| 29974324 | DISPLAY SCREEN OR PORTION THEREOF WITH GAME BOARD GUI | November 2024 | September 2025 | Allow | 10 | 0 | 0 | No | No |
| 29972941 | DISPLAY PANEL OR PORTION THEREOF WITH GRAPHICAL USER INTERFACE | November 2024 | September 2025 | Allow | 10 | 0 | 0 | No | No |
| 29972028 | Display Screen with Animated Graphical User Interface of a Gaming Machine | November 2024 | August 2025 | Allow | 10 | 0 | 0 | No | No |
| 29967916 | Type Font | October 2024 | August 2025 | Allow | 10 | 0 | 0 | No | No |
| 29961722 | DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACE | September 2024 | June 2025 | Allow | 9 | 0 | 0 | No | No |
| 35522545 | Typeface | August 2024 | May 2025 | Allow | 8 | 0 | 0 | No | No |
| 29957551 | DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACE | August 2024 | June 2025 | Allow | 10 | 0 | 0 | No | No |
| 29954754 | Display Screen or Portion Thereof with Transitional Graphical User Interface | July 2024 | June 2025 | Allow | 10 | 0 | 0 | No | No |
| 29951090 | TYPEFACE | July 2024 | August 2025 | Allow | 13 | 0 | 0 | No | No |
| 35521952 | Typographic typeface | June 2024 | April 2025 | Allow | 10 | 0 | 0 | No | No |
| 29946563 | DISPLAY SCREEN OR PORTION THEREOF WITH A GRAPHICAL USER INTERFACE | June 2024 | June 2025 | Allow | 12 | 0 | 0 | No | No |
| 29946071 | TYPEFACE | June 2024 | August 2025 | Allow | 14 | 0 | 0 | No | No |
| 29943400 | DISPLAY SCREEN OR PORTION THEREOF WITH A TRANSITIONAL GRAPHICAL USER INTERFACE | May 2024 | July 2025 | Allow | 14 | 0 | 0 | No | No |
| 29940433 | TYPEFACE | May 2024 | August 2025 | Allow | 16 | 0 | 0 | No | No |
| 29939376 | DISPLAY SCREEN WITH GRAPHICAL USER INTERFACE | April 2024 | June 2024 | Allow | 2 | 1 | 0 | Yes | No |
| 29939373 | DISPLAY SCREEN WITH GRAPHICAL USER INTERFACE | April 2024 | June 2024 | Allow | 2 | 1 | 0 | Yes | No |
| 29938944 | DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACE | April 2024 | January 2025 | Allow | 9 | 0 | 0 | No | No |
| 29935942 | TYPE FONT | April 2024 | August 2025 | Allow | 16 | 0 | 0 | No | No |
| 29935941 | TYPE FONT | April 2024 | August 2025 | Allow | 16 | 0 | 0 | No | No |
| 29935752 | Typeface or Type Font | April 2024 | May 2025 | Allow | 13 | 0 | 0 | No | No |
| 29934483 | Typeface | March 2024 | August 2025 | Allow | 17 | 0 | 0 | No | No |
| 29933834 | DISPLAY DEVICE WITH GRAPHICAL USER INTERFACE | March 2024 | June 2024 | Allow | 3 | 0 | 0 | No | No |
| 29933767 | TYPE FONT | March 2024 | August 2025 | Allow | 17 | 0 | 0 | No | No |
| 35522415 | Typeface | March 2024 | April 2025 | Allow | 14 | 0 | 0 | No | No |
| 29930639 | TYPE FONT | March 2024 | August 2025 | Allow | 17 | 0 | 0 | No | No |
| 35524166 | Display screen or portion thereof with animated graphical user interface | February 2024 | October 2025 | Allow | 20 | 0 | 0 | No | No |
| 29927944 | DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACE | February 2024 | July 2025 | Allow | 17 | 0 | 0 | No | No |
| 29927727 | TYPEFACE OR TYPE FONT | February 2024 | October 2025 | Allow | 20 | 0 | 0 | No | No |
| 29927725 | TYPEFACE OR TYPE FONT | February 2024 | October 2025 | Allow | 20 | 0 | 0 | No | No |
| 35520089 | Computer screen with transitional graphical user interface | February 2024 | January 2025 | Allow | 11 | 0 | 1 | No | No |
| 29925518 | TYPEFACE | January 2024 | April 2025 | Allow | 15 | 0 | 0 | No | No |
| 29921051 | DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACE | December 2023 | August 2025 | Allow | 20 | 0 | 0 | No | No |
| 29920403 | TYPE FONT | December 2023 | May 2025 | Allow | 17 | 0 | 0 | No | No |
| 29916253 | TYPE FONT | November 2023 | May 2025 | Allow | 18 | 0 | 0 | No | No |
| 35519606 | Display Screen with Graphical User Interface | October 2023 | December 2024 | Allow | 14 | 0 | 1 | No | No |
| 35519607 | DISPLAY SCREEN WITH TRANSITIONAL GRAPHICAL USER INTERFACE | October 2023 | December 2024 | Allow | 14 | 0 | 1 | No | No |
| 29915184 | TYPE FONT | October 2023 | May 2025 | Allow | 19 | 0 | 0 | No | No |
| 29914809 | DISPLAY SCREEN OR PORTION THEREOF WITH ANIMATED GRAPHICAL USER INTERFACE | October 2023 | July 2025 | Allow | 21 | 0 | 0 | No | No |
| 29913769 | TYPE FONT | October 2023 | May 2025 | Allow | 19 | 0 | 0 | No | No |
| 29904543 | DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACE | October 2023 | June 2025 | Allow | 20 | 0 | 0 | No | No |
| 35522400 | Printing Type | September 2023 | April 2025 | Allow | 7 | 0 | 0 | No | No |
| 29911769 | DISPLAY WITH ICON FOR ORAL-CARE APPLIANCE | September 2023 | November 2023 | Allow | 2 | 0 | 0 | No | No |
| 29911781 | DISPLAY WITH ICON FOR ORAL-CARE APPLIANCE | September 2023 | July 2025 | Allow | 22 | 0 | 0 | No | No |
| 29911774 | DISPLAY WITH ICON FOR ORAL-CARE APPLIANCE | September 2023 | July 2025 | Allow | 22 | 0 | 0 | No | No |
| 29911763 | DISPLAY WITH ICON FOR ORAL-CARE APPLIANCE | September 2023 | March 2024 | Allow | 6 | 0 | 0 | No | No |
| 29911765 | DISPLAY WITH ICON FOR ORAL-CARE APPLIANCE | September 2023 | July 2025 | Allow | 22 | 0 | 0 | No | No |
| 29911777 | DISPLAY WITH ICON FOR ORAL-CARE APPLIANCE | September 2023 | April 2024 | Allow | 7 | 0 | 0 | No | No |
| 29911768 | DISPLAY WITH ICON FOR ORAL-CARE APPLIANCE | September 2023 | March 2024 | Allow | 6 | 0 | 0 | No | No |
| 29911770 | DISPLAY WITH ICON FOR ORAL-CARE APPLIANCE | September 2023 | July 2025 | Allow | 22 | 0 | 0 | No | No |
| 29899550 | DISPLAY PANEL WITH GRAPHICAL USER INTERFACE | August 2023 | April 2025 | Allow | 20 | 0 | 0 | No | No |
| 29909532 | DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACE | August 2023 | April 2024 | Allow | 8 | 0 | 0 | No | No |
| 29909057 | DISPLAY SCREEN OR PORTION THEREOF WITH TRANSITIONAL GRAPHICAL USER INTERFACE | July 2023 | October 2023 | Allow | 2 | 0 | 0 | No | No |
| 29880607 | DISPLAY SCREEN WITH ANIMATED GRAPHICAL USER INTERFACE | July 2023 | April 2025 | Allow | 20 | 0 | 0 | No | No |
| 29896415 | TYPEFACE | July 2023 | April 2025 | Allow | 22 | 0 | 0 | No | No |
| 29896424 | TYPEFACE | July 2023 | April 2025 | Allow | 22 | 0 | 0 | No | No |
| 29894964 | DISPLAY SCREEN OR PORTION THEREOF WITH ANIMATED GRAPHICAL USER INTERFACE | June 2023 | June 2025 | Allow | 24 | 0 | 0 | No | No |
| 29877986 | TYPE FONT | June 2023 | April 2025 | Allow | 22 | 0 | 0 | No | No |
| 29877608 | TYPEFACE | June 2023 | April 2025 | Allow | 22 | 0 | 0 | No | No |
| 29893815 | Display Screen or Portion Thereof With Graphical User Interface | June 2023 | July 2023 | Allow | 1 | 0 | 0 | No | No |
| 29893822 | Display Screen or Portion Thereof With Graphical User Interface | June 2023 | September 2023 | Allow | 4 | 0 | 0 | No | No |
| 29893274 | TYPE FONT FOR THE BLIND | May 2023 | May 2025 | Allow | 23 | 0 | 0 | No | No |
| 29891260 | Display Screen with Transitional Graphical User Interface | May 2023 | July 2023 | Allow | 3 | 0 | 0 | No | No |
| 29891080 | Display Screen with Animated Graphical User Interface | May 2023 | July 2025 | Allow | 27 | 0 | 0 | No | No |
| 29890242 | DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACE | April 2023 | July 2023 | Allow | 2 | 0 | 0 | No | No |
| 29890147 | DISPLAY SCREEN OR PORTION THEREOF WITH GRAPHICAL USER INTERFACE | April 2023 | October 2023 | Allow | 6 | 0 | 0 | No | No |
| 29889715 | TYPE FONT | April 2023 | April 2025 | Allow | 24 | 0 | 0 | No | No |
| 29889716 | TYPE FONT | April 2023 | April 2025 | Allow | 24 | 0 | 0 | No | No |
| 29889446 | TYPE FONT | April 2023 | April 2025 | Allow | 24 | 0 | 0 | No | No |
| 29888127 | DISPLAY SCREEN OR PORTION THEREOF WITH ICON | March 2023 | October 2023 | Allow | 6 | 0 | 0 | No | No |
| 29873104 | DISPLAY SCREEN OR PORTION THEREOF WITH ANIMATED GRAPHICAL USER INTERFACE | March 2023 | July 2023 | Allow | 4 | 0 | 0 | No | No |
| 29873106 | DISPLAY SCREEN OR PORTION THEREOF WITH ANIMATED GRAPHICAL USER INTERFACE | March 2023 | June 2025 | Allow | 27 | 0 | 0 | No | No |
| 29873107 | DISPLAY SCREEN OR PORTION THEREOF WITH ANIMATED GRAPHICAL USER INTERFACE | March 2023 | July 2023 | Allow | 4 | 0 | 0 | No | No |
| 29873102 | DISPLAY SCREEN OR PORTION THEREOF WITH ANIMATED GRAPHICAL USER INTERFACE | March 2023 | January 2024 | Allow | 9 | 0 | 0 | No | No |
| 29887889 | CELL COUNTER DISPLAY SCREEN WITH GRAPHICAL USER INTERFACE | March 2023 | July 2023 | Allow | 4 | 0 | 0 | No | No |
| 29872854 | Display Screen or Portion Thereof with Transitional Graphical User Interface | March 2023 | May 2025 | Allow | 26 | 0 | 0 | No | No |
| 29887179 | Display Screen or Portion Thereof With Graphical User Interface | March 2023 | May 2023 | Allow | 2 | 0 | 0 | No | No |
| 29886838 | Display Screen or Portion Thereof With Graphical User Interface | March 2023 | April 2023 | Allow | 1 | 0 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner ROBINSON, CARY MICHAEL.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 100.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner ROBINSON, CARY MICHAEL works in Art Unit 2923 and has examined 1,266 patent applications in our dataset. With an allowance rate of 97.9%, this examiner allows applications at a higher rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 15 months.
Examiner ROBINSON, CARY MICHAEL's allowance rate of 97.9% places them in the 90% percentile among all USPTO examiners. This examiner is more likely to allow applications than most examiners at the USPTO.
On average, applications examined by ROBINSON, CARY MICHAEL receive 0.31 office actions before reaching final disposition. This places the examiner in the 1% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.
The median time to disposition (half-life) for applications examined by ROBINSON, CARY MICHAEL is 15 months. This places the examiner in the 99% percentile for prosecution speed. Applications move through prosecution relatively quickly with this examiner.
Conducting an examiner interview provides a -1.9% benefit to allowance rate for applications examined by ROBINSON, CARY MICHAEL. This interview benefit is in the 9% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.
When applicants file an RCE with this examiner, 100.0% of applications are subsequently allowed. This success rate is in the 100% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.
This examiner enters after-final amendments leading to allowance in 70.0% of cases where such amendments are filed. This entry rate is in the 92% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.
When applicants request a pre-appeal conference (PAC) with this examiner, 200.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 97% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 96% percentile among all examiners. Of these withdrawals, 100.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 38.7% are granted (fully or in part). This grant rate is in the 28% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 30% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 21.8% of allowed cases (in the 94% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.